Replies to post #4546 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

I don’t think so—hostile takeovers in the biotech industry are extremely rare. A takeover by ABBV, specifically, can be ruled out since it would never pass muster with antitrust regulators.

[marthambles]

Emanow, are you aware of whether any of the other toxin companies have announced price cuts in response to Revance?

Thanks